220 related articles for article (PubMed ID: 27764176)
1. A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agen.
Sugawara K; Honda K; Reien Y; Yokoi N; Seki C; Takahashi H; Minami K; Mori I; Matsumoto A; Nakaya H; Seino S
PLoS One; 2016; 11(10):e0164785. PubMed ID: 27764176
[TBL] [Abstract][Full Text] [Related]
2. Insulin stimulus-secretion coupling is triggered by a novel thiazolidinedione/sulfonylurea hybrid in rat pancreatic islets.
Mendes CP; Postal BG; Oliveira GTC; Castro AJG; Frederico MJS; Moraes ALL; Neuenfeldt PD; Nunes RJ; Menegaz D; Silva FRMB
J Cell Physiol; 2018 Jan; 234(1):509-520. PubMed ID: 29968920
[TBL] [Abstract][Full Text] [Related]
3. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.
Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T
J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916
[TBL] [Abstract][Full Text] [Related]
4.
Zambrana S; Lundqvist LCE; Mamani O; Catrina SB; Gonzales E; Östenson CG
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037028
[No Abstract] [Full Text] [Related]
5. Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels.
Geng X; Li L; Bottino R; Balamurugan AN; Bertera S; Densmore E; Su A; Chang Y; Trucco M; Drain P
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E293-301. PubMed ID: 17405830
[TBL] [Abstract][Full Text] [Related]
6. The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs.
Zhang CL; Katoh M; Shibasaki T; Minami K; Sunaga Y; Takahashi H; Yokoi N; Iwasaki M; Miki T; Seino S
Science; 2009 Jul; 325(5940):607-10. PubMed ID: 19644119
[TBL] [Abstract][Full Text] [Related]
7. Preclinical characterization of 55P0251, a novel compound that amplifies glucose-stimulated insulin secretion and counteracts hyperglycaemia in rodents.
Stadlbauer K; Brunmair B; Lehner Z; Adorjan I; Scherer T; Luger A; Bauer L; Fürnsinn C
Diabetes Obes Metab; 2017 Aug; 19(8):1088-1096. PubMed ID: 28211608
[TBL] [Abstract][Full Text] [Related]
8. Rapid insulinotropic effect of 17beta-estradiol via a plasma membrane receptor.
Nadal A; Rovira JM; Laribi O; Leon-quinto T; Andreu E; Ripoll C; Soria B
FASEB J; 1998 Oct; 12(13):1341-8. PubMed ID: 9761777
[TBL] [Abstract][Full Text] [Related]
9. Novel sulfonyl(thio)urea derivatives act efficiently both as insulin secretagogues and as insulinomimetic compounds.
Mascarello A; Frederico MJ; Castro AJ; Mendes CP; Dutra MF; Woehl VM; Yunes RA; Mena Barreto Silva FR; Nunes RJ
Eur J Med Chem; 2014 Oct; 86():491-501. PubMed ID: 25203779
[TBL] [Abstract][Full Text] [Related]
10. Dextromethorphan and Dextrorphan Influence Insulin Secretion by Interacting with K
Gresch A; Düfer M
J Pharmacol Exp Ther; 2020 Oct; 375(1):10-20. PubMed ID: 32665318
[TBL] [Abstract][Full Text] [Related]
11. Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells.
Remedi MS; Nichols CG
PLoS Med; 2008 Oct; 5(10):e206. PubMed ID: 18959471
[TBL] [Abstract][Full Text] [Related]
12. Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
Winkler M; Stephan D; Bieger S; Kühner P; Wolff F; Quast U
J Pharmacol Exp Ther; 2007 Aug; 322(2):701-8. PubMed ID: 17495126
[TBL] [Abstract][Full Text] [Related]
13. Restitution of defective glucose-stimulated insulin release of sulfonylurea type 1 receptor knockout mice by acetylcholine.
Doliba NM; Qin W; Vatamaniuk MZ; Li C; Zelent D; Najafi H; Buettger CW; Collins HW; Carr RD; Magnuson MA; Matschinsky FM
Am J Physiol Endocrinol Metab; 2004 May; 286(5):E834-43. PubMed ID: 14736703
[TBL] [Abstract][Full Text] [Related]
14. Exchange protein directly activated by cyclic AMP isoform 2 is not a direct target of sulfonylurea drugs.
Tsalkova T; Gribenko AV; Cheng X
Assay Drug Dev Technol; 2011 Feb; 9(1):88-91. PubMed ID: 21133673
[TBL] [Abstract][Full Text] [Related]
15. Extract isolated from Angelica hirsutiflora with insulin secretagogue activity.
Leu YL; Chen YW; Yang CY; Huang CF; Lin GH; Tsai KS; Yang RS; Liu SH
J Ethnopharmacol; 2009 Jun; 123(2):208-12. PubMed ID: 19429364
[TBL] [Abstract][Full Text] [Related]
16. A signaling role of glutamine in insulin secretion.
Li C; Buettger C; Kwagh J; Matter A; Daikhin Y; Nissim IB; Collins HW; Yudkoff M; Stanley CA; Matschinsky FM
J Biol Chem; 2004 Apr; 279(14):13393-401. PubMed ID: 14736887
[TBL] [Abstract][Full Text] [Related]
17. Effect of 1-[4- [2-(4-bromobenzenesulfonamino) ethyl] phenylsulfonyl]-3-(trans-4-methylcyclohexyl)urea (I4), a new synthetic sulfonylurea compound, on glucose metabolism in vivo and in vitro.
Wu GZ; Hong G; Zhang WP; Zhang HB
Arzneimittelforschung; 2009; 59(11):550-6. PubMed ID: 20066963
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of K+ channels and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets.
Schwanstecher M; Mnner K; Panten U
Pharmacology; 1994 Aug; 49(2):105-11. PubMed ID: 7972319
[TBL] [Abstract][Full Text] [Related]
19. Eugenosedin-A improves obesity-related hyperglycemia by regulating ATP-sensitive K
Lin RJ; Yen YK; Lee CH; Hsieh SL; Chang YC; Juan YS; Long CY; Shen KP; Wu BN
Biomed Pharmacother; 2022 Jan; 145():112447. PubMed ID: 34808553
[TBL] [Abstract][Full Text] [Related]
20. Eriodictyol stimulates insulin secretion through cAMP/PKA signaling pathway in mice islets.
Hameed A; Hafizur RM; Hussain N; Raza SA; Rehman M; Ashraf S; Ul-Haq Z; Khan F; Abbas G; Choudhary MI
Eur J Pharmacol; 2018 Feb; 820():245-255. PubMed ID: 29229531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
